Key Points
- Christophe Mossé appointed as CEO of Arkopharma group
- He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
- Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- Virbac announces changes in its executive management
- Virbac finalizes acquisition of minority stake in Globion, Indian poultry vaccine specialist.
- Christophe Mossé appointed as CEO of Arkopharma group
- Nucleate France UniCA strengthens the ties between research, industry, and entrepreneurship in life sciences.
- Team Nice Côte d’Azur in force at Viva Tech 2024
- New urban health trail in Nice
- Quantum Genomics is now the sole holder of all the shares and voting rights of Exactcure
- Caranx Medical Innovates in Robotic-Assisted Heart Valve Implantation
- €8 million investment to transform Archet 2 hospital in Nice
- Nice Côte d’Azur: Oncology Excellence Showcased During Business Tour
